| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | regulation of mesenchymal stem cell differentiation | 2.92e-06 | 11 | 55 | 3 | GO:2000739 | |
| GeneOntologyBiologicalProcess | mesenchymal stem cell differentiation | 6.40e-06 | 14 | 55 | 3 | GO:0072497 | |
| GeneOntologyBiologicalProcess | positive regulation of mesenchymal stem cell differentiation | 4.17e-05 | 4 | 55 | 2 | GO:2000741 | |
| Domain | Ribosomal_S26e | 8.51e-06 | 2 | 55 | 2 | IPR000892 | |
| Domain | RIBOSOMAL_S26E | 8.51e-06 | 2 | 55 | 2 | PS00733 | |
| Domain | Ribosomal_S26e | 8.51e-06 | 2 | 55 | 2 | PF01283 | |
| Domain | MYTH4 | 3.02e-04 | 9 | 55 | 2 | PS51016 | |
| Domain | MyTH4_dom | 3.02e-04 | 9 | 55 | 2 | IPR000857 | |
| Domain | MyTH4 | 3.02e-04 | 9 | 55 | 2 | PF00784 | |
| Domain | MyTH4 | 3.02e-04 | 9 | 55 | 2 | SM00139 | |
| Domain | FERM_central | 4.04e-04 | 49 | 55 | 3 | IPR019748 | |
| Domain | FERM_domain | 4.04e-04 | 49 | 55 | 3 | IPR000299 | |
| Domain | FERM_1 | 4.29e-04 | 50 | 55 | 3 | PS00660 | |
| Domain | FERM_2 | 4.29e-04 | 50 | 55 | 3 | PS00661 | |
| Domain | FERM_3 | 4.29e-04 | 50 | 55 | 3 | PS50057 | |
| Domain | Band_41_domain | 4.29e-04 | 50 | 55 | 3 | IPR019749 | |
| Domain | B41 | 4.29e-04 | 50 | 55 | 3 | SM00295 | |
| Domain | DOCK_C | 4.60e-04 | 11 | 55 | 2 | IPR010703 | |
| Domain | DHR-1_domain | 4.60e-04 | 11 | 55 | 2 | IPR027007 | |
| Domain | DHR_2 | 4.60e-04 | 11 | 55 | 2 | PS51651 | |
| Domain | DHR_1 | 4.60e-04 | 11 | 55 | 2 | PS51650 | |
| Domain | DOCK-C2 | 4.60e-04 | 11 | 55 | 2 | PF14429 | |
| Domain | DHR-2 | 4.60e-04 | 11 | 55 | 2 | IPR027357 | |
| Domain | DHR-2 | 4.60e-04 | 11 | 55 | 2 | PF06920 | |
| Domain | DOCK | 4.60e-04 | 11 | 55 | 2 | IPR026791 | |
| Domain | Dynein_heavy_chain_D4_dom | 7.57e-04 | 14 | 55 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 7.57e-04 | 14 | 55 | 2 | IPR024743 | |
| Domain | MT | 7.57e-04 | 14 | 55 | 2 | PF12777 | |
| Domain | AAA_8 | 7.57e-04 | 14 | 55 | 2 | PF12780 | |
| Domain | DHC_fam | 8.72e-04 | 15 | 55 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 8.72e-04 | 15 | 55 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 8.72e-04 | 15 | 55 | 2 | PF03028 | |
| Domain | Furin_repeat | 1.26e-03 | 18 | 55 | 2 | IPR006212 | |
| Domain | FU | 1.26e-03 | 18 | 55 | 2 | SM00261 | |
| Domain | tRNA-bd_arm | 2.25e-03 | 24 | 55 | 2 | IPR010978 | |
| Domain | P-loop_NTPase | 3.20e-03 | 848 | 55 | 8 | IPR027417 | |
| Domain | - | 3.21e-03 | 207 | 55 | 4 | 1.25.40.10 | |
| Domain | TPR-like_helical_dom | 4.89e-03 | 233 | 55 | 4 | IPR011990 | |
| Domain | RA | 5.03e-03 | 36 | 55 | 2 | PF00788 | |
| Domain | Myosin_head_motor_dom | 5.59e-03 | 38 | 55 | 2 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 5.59e-03 | 38 | 55 | 2 | PS51456 | |
| Domain | Myosin_head | 5.59e-03 | 38 | 55 | 2 | PF00063 | |
| Domain | MYSc | 5.59e-03 | 38 | 55 | 2 | SM00242 | |
| Domain | - | 6.04e-03 | 746 | 55 | 7 | 3.40.50.300 | |
| Domain | RA_dom | 6.18e-03 | 40 | 55 | 2 | IPR000159 | |
| Domain | FERM_M | 8.11e-03 | 46 | 55 | 2 | PF00373 | |
| Domain | PH_dom-like | 8.23e-03 | 426 | 55 | 5 | IPR011993 | |
| Domain | - | 9.16e-03 | 49 | 55 | 2 | 1.20.80.10 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 9.53e-03 | 50 | 55 | 2 | IPR014352 | |
| Domain | TPR_2 | 9.53e-03 | 50 | 55 | 2 | PF07719 | |
| Domain | TPR_2 | 9.53e-03 | 50 | 55 | 2 | IPR013105 | |
| Domain | HMG_box | 1.07e-02 | 53 | 55 | 2 | PF00505 | |
| Domain | TPR_8 | 1.07e-02 | 53 | 55 | 2 | PF13181 | |
| Domain | HMG_BOX_2 | 1.10e-02 | 54 | 55 | 2 | PS50118 | |
| Domain | HMG | 1.10e-02 | 54 | 55 | 2 | SM00398 | |
| Domain | - | 1.14e-02 | 55 | 55 | 2 | 1.10.30.10 | |
| Pubmed | Mechanism of STAT3 activation by insulin-like growth factor I receptor. | 2.73e-06 | 2 | 58 | 2 | 10747872 | |
| Pubmed | Generation of mice harboring a Sox5 conditional null allele. | 2.73e-06 | 2 | 58 | 2 | 18543318 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 11585348 | ||
| Pubmed | 3.93e-06 | 251 | 58 | 6 | 29031500 | ||
| Pubmed | SoxD genes are required for adult neural stem cell activation. | 8.19e-06 | 3 | 58 | 2 | 35108528 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 34876132 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 26150426 | ||
| Pubmed | Generation of mice harboring a Sox6 conditional null allele. | 8.19e-06 | 3 | 58 | 2 | 16652367 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 15529345 | ||
| Pubmed | SOX trio decrease in the articular cartilage with the advancement of osteoarthritis. | 8.19e-06 | 3 | 58 | 2 | 21728837 | |
| Pubmed | SOX5/6/21 Prevent Oncogene-Driven Transformation of Brain Stem Cells. | 8.19e-06 | 3 | 58 | 2 | 28687615 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 21401405 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 30983072 | ||
| Pubmed | CFTR interactome mapping using the mammalian membrane two-hybrid high-throughput screening system. | 8.53e-06 | 440 | 58 | 7 | 35156780 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 23857432 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 18559420 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 32960357 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 8690736 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 21262861 | ||
| Pubmed | Dynamic epigenetic mechanisms regulate age-dependent SOX9 expression in mouse articular cartilage. | 1.64e-05 | 4 | 58 | 2 | 26806292 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 19759178 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 20940257 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 9727029 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 28924044 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 9492017 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 16627753 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 15767667 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DOCK1 ZNF462 JAK2 EFNA1 IGF1R ARHGEF38 SHPRH RNF213 CSMD1 RXRA DNAH14 | 3.04e-05 | 1489 | 58 | 11 | 28611215 |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | EFNA1 AGO3 RAPH1 MYO7A MYO10 SULT1C3 ARHGEF38 CSMD1 LRMDA DOP1B | 3.57e-05 | 1242 | 58 | 10 | 30973865 |
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 22547066 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 9755172 | ||
| Pubmed | 5.63e-05 | 808 | 58 | 8 | 20412781 | ||
| Pubmed | 5.71e-05 | 7 | 58 | 2 | 11212352 | ||
| Pubmed | 5.71e-05 | 7 | 58 | 2 | 2482828 | ||
| Pubmed | Pairing SOX off: with partners in the regulation of embryonic development. | 5.71e-05 | 7 | 58 | 2 | 10729834 | |
| Pubmed | 5.71e-05 | 7 | 58 | 2 | 20181744 | ||
| Pubmed | 5.71e-05 | 7 | 58 | 2 | 19754311 | ||
| Pubmed | The transcription factor Sox5 modulates Sox10 function during melanocyte development. | 7.60e-05 | 8 | 58 | 2 | 18703590 | |
| Pubmed | A conserved family of genes related to the testis determining gene, SRY. | 7.60e-05 | 8 | 58 | 2 | 1614875 | |
| Pubmed | 7.60e-05 | 8 | 58 | 2 | 26345464 | ||
| Pubmed | 7.60e-05 | 8 | 58 | 2 | 33570491 | ||
| Pubmed | 9.77e-05 | 9 | 58 | 2 | 26692333 | ||
| Pubmed | 9.77e-05 | 9 | 58 | 2 | 28630873 | ||
| Pubmed | Translational Control of Sox9 RNA by mTORC1 Contributes to Skeletogenesis. | 9.77e-05 | 9 | 58 | 2 | 30008325 | |
| Pubmed | 9.77e-05 | 9 | 58 | 2 | 15044591 | ||
| Pubmed | Essential role of Sox9 in the pathway that controls formation of cardiac valves and septa. | 1.22e-04 | 10 | 58 | 2 | 15096597 | |
| Pubmed | 1.22e-04 | 10 | 58 | 2 | 10037800 | ||
| Pubmed | An Atoh1-S193A Phospho-Mutant Allele Causes Hearing Deficits and Motor Impairment. | 1.49e-04 | 11 | 58 | 2 | 28729444 | |
| Pubmed | 1.49e-04 | 11 | 58 | 2 | 16678811 | ||
| Pubmed | Bmpr1a and Bmpr1b have overlapping functions and are essential for chondrogenesis in vivo. | 1.49e-04 | 11 | 58 | 2 | 15781876 | |
| Pubmed | Hif-1alpha regulates differentiation of limb bud mesenchyme and joint development. | 1.49e-04 | 11 | 58 | 2 | 17470636 | |
| Pubmed | 1.78e-04 | 12 | 58 | 2 | 26525805 | ||
| Pubmed | 1.78e-04 | 12 | 58 | 2 | 21945074 | ||
| Pubmed | 1.78e-04 | 12 | 58 | 2 | 34234180 | ||
| Pubmed | Genome-wide association analysis identifies three psoriasis susceptibility loci. | 2.11e-04 | 13 | 58 | 2 | 20953189 | |
| Pubmed | SOX2-LIN28/let-7 pathway regulates proliferation and neurogenesis in neural precursors. | 2.11e-04 | 13 | 58 | 2 | 23884650 | |
| Pubmed | 2.11e-04 | 13 | 58 | 2 | 27160681 | ||
| Pubmed | 2.11e-04 | 13 | 58 | 2 | 25293881 | ||
| Pubmed | 2.11e-04 | 13 | 58 | 2 | 15634692 | ||
| Pubmed | 2.11e-04 | 13 | 58 | 2 | 22735158 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 2.18e-04 | 736 | 58 | 7 | 29676528 | |
| Pubmed | Cytoneme signaling provides essential contributions to mammalian tissue patterning. | 2.46e-04 | 14 | 58 | 2 | 38171360 | |
| Pubmed | 2.46e-04 | 14 | 58 | 2 | 8921394 | ||
| Pubmed | 2.46e-04 | 14 | 58 | 2 | 12432077 | ||
| Pubmed | Cbfb2 Isoform Dominates More Potent Cbfb1 and Is Required for Skeletal Development. | 2.83e-04 | 15 | 58 | 2 | 26890219 | |
| Pubmed | 2.83e-04 | 15 | 58 | 2 | 20206616 | ||
| Pubmed | Differential isoform expression and alternative splicing in sex determination in mice. | 2.83e-04 | 15 | 58 | 2 | 30871468 | |
| Pubmed | 2.83e-04 | 15 | 58 | 2 | 14993235 | ||
| Pubmed | Misexpression of Sox9 in mouse limb bud mesenchyme induces polydactyly and rescues hypodactyly mice. | 3.23e-04 | 16 | 58 | 2 | 17222543 | |
| Pubmed | Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice. | 3.23e-04 | 16 | 58 | 2 | 16096065 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | 3.62e-04 | 1061 | 58 | 8 | 33845483 | |
| Pubmed | Musculoskeletal integration at the wrist underlies the modular development of limb tendons. | 3.66e-04 | 17 | 58 | 2 | 26062940 | |
| Pubmed | Spatio-temporal expression of Sox genes in murine palatogenesis. | 3.66e-04 | 17 | 58 | 2 | 27241892 | |
| Pubmed | Cbfb regulates bone development by stabilizing Runx family proteins. | 3.66e-04 | 17 | 58 | 2 | 25262822 | |
| Pubmed | The cell-intrinsic requirement of Sox6 for cortical interneuron development. | 4.11e-04 | 18 | 58 | 2 | 19709629 | |
| Pubmed | 4.11e-04 | 18 | 58 | 2 | 29899135 | ||
| Pubmed | 4.11e-04 | 18 | 58 | 2 | 12571105 | ||
| Pubmed | 4.11e-04 | 18 | 58 | 2 | 26864488 | ||
| Pubmed | 4.59e-04 | 19 | 58 | 2 | 24564958 | ||
| Pubmed | 5.09e-04 | 20 | 58 | 2 | 11404013 | ||
| Pubmed | The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. | 5.09e-04 | 20 | 58 | 2 | 11702786 | |
| Pubmed | 5.62e-04 | 21 | 58 | 2 | 29659575 | ||
| Pubmed | HES1 is a novel downstream modifier of the SHH-GLI3 Axis in the development of preaxial polydactyly. | 5.62e-04 | 21 | 58 | 2 | 34928956 | |
| Pubmed | Temporomandibular joint formation requires two distinct hedgehog-dependent steps. | 5.62e-04 | 21 | 58 | 2 | 19815519 | |
| Pubmed | SOX6 controls dorsal progenitor identity and interneuron diversity during neocortical development. | 5.62e-04 | 21 | 58 | 2 | 19657336 | |
| Pubmed | Multiple roles and interactions of Tbx4 and Tbx5 in development of the respiratory system. | 5.62e-04 | 21 | 58 | 2 | 22876201 | |
| Pubmed | 5.62e-04 | 21 | 58 | 2 | 30021842 | ||
| Pubmed | 6.18e-04 | 22 | 58 | 2 | 17084361 | ||
| Pubmed | 6.18e-04 | 22 | 58 | 2 | 35902588 | ||
| Pubmed | 6.18e-04 | 22 | 58 | 2 | 27527664 | ||
| Pubmed | Ets1 is required for proper migration and differentiation of the cardiac neural crest. | 6.18e-04 | 22 | 58 | 2 | 20356956 | |
| Pubmed | 6.53e-04 | 101 | 58 | 3 | 18519826 | ||
| Pubmed | 7.37e-04 | 24 | 58 | 2 | 35790771 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 8.91e-04 | 256 | 58 | 4 | 33397691 | |
| Pubmed | 1.05e-03 | 463 | 58 | 5 | 27503909 | ||
| Pubmed | Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. | 1.23e-03 | 31 | 58 | 2 | 14684825 | |
| Pubmed | 1.31e-03 | 32 | 58 | 2 | 20111592 | ||
| Pubmed | 1.31e-03 | 32 | 58 | 2 | 24954895 | ||
| Pubmed | 1.31e-03 | 32 | 58 | 2 | 23704327 | ||
| Pubmed | 1.40e-03 | 33 | 58 | 2 | 12414734 | ||
| Cytoband | 13q32.3 | 4.04e-04 | 23 | 59 | 2 | 13q32.3 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 2.27e-04 | 50 | 43 | 3 | 1293 | |
| GeneFamily | Dyneins, axonemal | 7.35e-04 | 17 | 43 | 2 | 536 | |
| GeneFamily | SRY-boxes | 9.21e-04 | 19 | 43 | 2 | 757 | |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 1.86e-06 | 176 | 55 | 6 | M39223 | |
| Coexpression | LAKE_ADULT_KIDNEY_C13_THICK_ASCENDING_LIMB | 8.22e-06 | 131 | 55 | 5 | M39232 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | MORC1 SOX6 ZNF462 SOX5 PCSK5 MYO10 COG7 SMC4 RNF213 RNF17 PRDM14 | 3.20e-06 | 806 | 52 | 11 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | 1.58e-05 | 776 | 52 | 10 | gudmap_developingGonad_e14.5_ ovary_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#1_top-relative-expression-ranked_500 | 2.08e-05 | 231 | 52 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.91e-05 | 397 | 52 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_500 | 7.18e-05 | 33 | 52 | 3 | gudmap_developingGonad_P2_ovary_500_k5 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | 9.39e-05 | 770 | 52 | 9 | gudmap_developingGonad_P2_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | 1.20e-04 | 795 | 52 | 9 | gudmap_developingGonad_e16.5_ovary_1000 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-07 | 194 | 56 | 6 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Necab1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.42e-07 | 126 | 56 | 5 | 28fbe63f7bc628b32d8e86bf9e80657e776dd1cc | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.82e-06 | 161 | 56 | 5 | 76c993a4533362db2250c88b3ee3ede55362d54e | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.24e-06 | 168 | 56 | 5 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.97e-06 | 178 | 56 | 5 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.31e-06 | 182 | 56 | 5 | 8a8b08ac4bb3cba3541dbe234e088703842285b9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.31e-06 | 182 | 56 | 5 | e36766309c4d96a90d213ce37d3acef1029a3fdc | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.59e-06 | 185 | 56 | 5 | efc5d564f8793c751ba640aef60f761e4b081d3f | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.59e-06 | 185 | 56 | 5 | fba2dc46cd98ab9c78e788959c2121aa10d148b2 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.19e-06 | 191 | 56 | 5 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 4.30e-06 | 192 | 56 | 5 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-06 | 193 | 56 | 5 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.52e-06 | 194 | 56 | 5 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.52e-06 | 194 | 56 | 5 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.64e-06 | 195 | 56 | 5 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.75e-06 | 196 | 56 | 5 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.75e-06 | 196 | 56 | 5 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | control-CD163+_Monocytes_(Sample_ID1_d7)|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.12e-06 | 199 | 56 | 5 | 933201d32eda12a89660bdbae9114a95cc428a38 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.25e-06 | 200 | 56 | 5 | b5a54b9baf79aea01f76a161f0a39bbe87eb4945 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.25e-06 | 200 | 56 | 5 | f5bd0b30e478dac09f68c46b0781f5f2e7e3c693 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Necab1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.92e-05 | 126 | 56 | 4 | a4fc7ac4931d2fc8aa8196a62d809b698937aa9c | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac1_Htr1d|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.83e-05 | 139 | 56 | 4 | fe1657ef9aeda7c530dc7febcd3dcd0e1d5f8a48 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.90e-05 | 160 | 56 | 4 | dd16ca90feb3ae88b6409d6c278b4765da565514 | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_intermediate|World / disease group, cell group and cell class (v2) | 4.90e-05 | 160 | 56 | 4 | 6722934e153b72039c3c4308557d0ef879a30638 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.02e-05 | 161 | 56 | 4 | bf70be1de418615b5442ec684552551edaf1f072 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.02e-05 | 161 | 56 | 4 | 9703b7e67d9fadb6129cad166bd01be915042e44 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.14e-05 | 162 | 56 | 4 | 285e6d553f485fd9f1075c4e1b940da251b5ea35 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.39e-05 | 164 | 56 | 4 | 5638d95c7cc5e59c4a7bda30268a904a01861a5f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.39e-05 | 164 | 56 | 4 | 6fb2136168f430babfeb81ca7e151ca7a8092ec4 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.52e-05 | 165 | 56 | 4 | 1dcd6b8aa192baeaa1f7bb334843edab6049b96f | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.34e-05 | 171 | 56 | 4 | 845f312f8cbe29d820da25f0e6d75deb382bbfd8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.49e-05 | 172 | 56 | 4 | 08a3fe536b1b064c5ee7779bc2b1115a5963a26b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.49e-05 | 172 | 56 | 4 | 553701349444eb366df3c11f54bb093434f153c6 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-stromal_related|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.94e-05 | 175 | 56 | 4 | 2fbffcb843f364645b99d1211698d96092abc5ef | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-stromal_related-Germ|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.94e-05 | 175 | 56 | 4 | d0d5ae2a9357aa183ab720c891d86b80c9822930 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.94e-05 | 175 | 56 | 4 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | 7.41e-05 | 178 | 56 | 4 | 278bbea5cf8f0589f71675c7a3d00679391b5253 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.57e-05 | 179 | 56 | 4 | d3438fed0d85d5ed5afa8ff820c45143d77b6c0d | |
| ToppCell | Mesenchymal_cells-Chondrocytes|Mesenchymal_cells / Lineage and Cell class | 7.74e-05 | 180 | 56 | 4 | 6e399368430ef3afa9ce1ef0ed90f614ccef9987 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.90e-05 | 181 | 56 | 4 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.07e-05 | 182 | 56 | 4 | a05e5978ef5f7fac7eeb2ba1c0103ea90d5e9136 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.07e-05 | 182 | 56 | 4 | 831b5ce46b41efe01c4db6016c2f43148611373d | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 8.07e-05 | 182 | 56 | 4 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.07e-05 | 182 | 56 | 4 | 3cc61f5f7ad4a81eba3daf65e122880b5af3adc0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.07e-05 | 182 | 56 | 4 | 5d909e4b5f662905bf1be9c686bbddc3e87d2be9 | |
| ToppCell | B_cells-ABCs|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 8.25e-05 | 183 | 56 | 4 | bf9c6fe3ce4e44e4056027257eab8448c39c4fb8 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-leukocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.25e-05 | 183 | 56 | 4 | 062ec08d66c923f90fee771b1bf8d98bdc7e6c1b | |
| ToppCell | Mild/Remission-B_intermediate-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.42e-05 | 184 | 56 | 4 | 3d4864605c812862cf8926e02370eea3b8ccf32f | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 8.60e-05 | 185 | 56 | 4 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.60e-05 | 185 | 56 | 4 | 2e1766f1a972fecd670daaaf7eb2d3a404f121e7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.60e-05 | 185 | 56 | 4 | 7aaa8335b40927e3e8fdcede807cd521fc213a0d | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.60e-05 | 185 | 56 | 4 | 53a5218c1e6eb12daccde3d6e02f337e2586d74c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.78e-05 | 186 | 56 | 4 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.78e-05 | 186 | 56 | 4 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 8.78e-05 | 186 | 56 | 4 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.78e-05 | 186 | 56 | 4 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.96e-05 | 187 | 56 | 4 | daff7ccd3f1924cf2b34d3aca3eccde245aaf371 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.96e-05 | 187 | 56 | 4 | 5b7a1edee602e55d3400dc17dbb6b8aaa26defc0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.15e-05 | 188 | 56 | 4 | 58ccb31cdf43167872ef0fc737e6f9c51ee2e060 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.15e-05 | 188 | 56 | 4 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 9.15e-05 | 188 | 56 | 4 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 9.34e-05 | 189 | 56 | 4 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.34e-05 | 189 | 56 | 4 | b2542b6fcf7bc10d29158d42b03182a939ff135a | |
| ToppCell | Control-B_intermediate-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 9.34e-05 | 189 | 56 | 4 | 11cb9a16f1de8f60af2073ed7ea6d4f41c02f299 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.34e-05 | 189 | 56 | 4 | 532aaf02b364c5c4f58a2021c7c21d86df3875c9 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.53e-05 | 190 | 56 | 4 | da58227565ad6a690828dd8554dd3670222f8582 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron|World / Primary Cells by Cluster | 9.73e-05 | 191 | 56 | 4 | 4dd9c8117c4499ed9bde127baf2598603a82080d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.92e-05 | 192 | 56 | 4 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-SST-MGE1|World / Primary Cells by Cluster | 9.92e-05 | 192 | 56 | 4 | bcc499f4c7ba2898ecd9c47bf68c92ed359b81ba | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.92e-05 | 192 | 56 | 4 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.92e-05 | 192 | 56 | 4 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 193 | 56 | 4 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | PCW_07-8.5|World / Celltypes from embryonic and fetal-stage human lung | 1.03e-04 | 194 | 56 | 4 | 5759c83308df017f1faae248e9b85388e25254f0 | |
| ToppCell | control-CD163+_Monocytes_(Sample_ID1_d7)|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.05e-04 | 195 | 56 | 4 | 19413dc6aa0010686cdfa0c750ef0a7a76caf308 | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.07e-04 | 196 | 56 | 4 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | Mild/Remission-B_intermediate-6|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.10e-04 | 197 | 56 | 4 | 5370dda4a25e3a53d6fe2c887b7dabd7a58462b4 | |
| ToppCell | mild-Myeloid|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.12e-04 | 198 | 56 | 4 | 908746384e10c6b833bb3bc124045d7b0bfd73b5 | |
| ToppCell | Severe-B_intermediate-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.12e-04 | 198 | 56 | 4 | 8402421dc060926e968efe39a4e907f1e8ae5b1f | |
| ToppCell | severe|World / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.14e-04 | 199 | 56 | 4 | c24aacef7405700bc5d0b736a38feea12b7f17c8 | |
| ToppCell | Severe-B_intermediate-6|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.14e-04 | 199 | 56 | 4 | bf6ebb63ab361d9d1946225894d7be433e9befab | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 56 | 4 | 5ec469267747dce3601c1d8ad01af89fa5b29acc | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.16e-04 | 200 | 56 | 4 | 38e681997913fcbc93f4e1715820e53844376eab | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-04 | 200 | 56 | 4 | b7b9441fa7ab0d43741a2ebd5ec1a48d537c6d47 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 56 | 4 | e79d93d55b25804f2608185168da472301b6ebca | |
| ToppCell | Sigmoid-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 1.16e-04 | 200 | 56 | 4 | cdb3f242d0c80b4eb9044f59156443e77fb81a1d | |
| ToppCell | severe-immature_Neutrophil|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.16e-04 | 200 | 56 | 4 | a9b87accdaa6956116ab82427e1330e8f007ef94 | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-04 | 200 | 56 | 4 | 7c673ad0ea503ebd196579684d25d5f9e6a41030 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 56 | 4 | 320d5a3a1e7da2fa8f1a164e29e180ec8ac9889c | |
| ToppCell | (6)_Macrophage-(61)_LYVE1_Macrophage|(6)_Macrophage / shred on Cell_type and subtype | 2.55e-04 | 98 | 56 | 3 | 30a9a2abd0487e818628db589d31f630ca4d894b | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Cbln4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.09e-04 | 115 | 56 | 3 | ac73aa06e617ed791c6ae9e38189bac74188c27b | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Prdm8|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.74e-04 | 121 | 56 | 3 | 2ae870f822488799cd0ad85e7f72af64e33a867f | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_ALM_Olfr111_Nxph1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.86e-04 | 122 | 56 | 3 | dba1c647172a11381efcb178a23808161908daa3 | |
| ToppCell | VE-CD4-CD8_2|VE / Condition, Cell_class and T cell subcluster | 4.86e-04 | 122 | 56 | 3 | 6745035feaf807b6a6b9537ac9d5ee0e000196eb | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Sema3c|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.86e-04 | 122 | 56 | 3 | eae9d94f8510ac0f434942451d55c7260977b178 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Nr2f2_Necab1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.09e-04 | 124 | 56 | 3 | 298ff8bd8f0459f44ce8a8aea889c6f1cf84ac5f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Cbln4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.33e-04 | 126 | 56 | 3 | 94bd9cfe982b41a3114885173eab55feb0fbbbae | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Nxph2_Wls|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.84e-04 | 130 | 56 | 3 | 05d5a73acf1d7f75a79876b1a06d27c74a89b8a4 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_P2ry12|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.97e-04 | 131 | 56 | 3 | 80630812f8894b9358d36dc2dd03fea7ee870502 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Col15a1_Pde1a|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.38e-04 | 134 | 56 | 3 | d63fff23040eada31bc35ba1e05b7c6a663e0037 | |
| ToppCell | Control-B_memory-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.66e-04 | 136 | 56 | 3 | 94f23bef50c0beb54ed39b1a4b340f7aec4e75cd | |
| Disease | Paroxysmal atrial fibrillation | 6.40e-07 | 156 | 58 | 6 | C0235480 | |
| Disease | familial atrial fibrillation | 6.40e-07 | 156 | 58 | 6 | C3468561 | |
| Disease | Persistent atrial fibrillation | 6.40e-07 | 156 | 58 | 6 | C2585653 | |
| Disease | Atrial Fibrillation | 7.42e-07 | 160 | 58 | 6 | C0004238 | |
| Disease | Drug habituation | 3.20e-06 | 115 | 58 | 5 | C0013170 | |
| Disease | Substance-Related Disorders | 3.20e-06 | 115 | 58 | 5 | C0236969 | |
| Disease | Drug abuse | 3.20e-06 | 115 | 58 | 5 | C0013146 | |
| Disease | Drug Use Disorders | 3.20e-06 | 115 | 58 | 5 | C0013222 | |
| Disease | Drug Dependence | 3.20e-06 | 115 | 58 | 5 | C1510472 | |
| Disease | Substance Dependence | 3.20e-06 | 115 | 58 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 3.20e-06 | 115 | 58 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 3.20e-06 | 115 | 58 | 5 | C0029231 | |
| Disease | Prescription Drug Abuse | 3.20e-06 | 115 | 58 | 5 | C4316881 | |
| Disease | Substance abuse problem | 3.34e-06 | 116 | 58 | 5 | C0740858 | |
| Disease | age at menarche | 2.03e-05 | 594 | 58 | 8 | EFO_0004703 | |
| Disease | atrial fibrillation | 8.85e-05 | 371 | 58 | 6 | EFO_0000275 | |
| Disease | Diamond-Blackfan anemia (implicated_via_orthology) | 1.69e-04 | 10 | 58 | 2 | DOID:1339 (implicated_via_orthology) | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 1.96e-04 | 57 | 58 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | phosphatidylcholine 40:6 measurement | 5.07e-04 | 17 | 58 | 2 | EFO_0010389 | |
| Disease | neuritic plaque measurement | 6.17e-04 | 349 | 58 | 5 | EFO_0006798 | |
| Disease | facial asymmetry measurement | 6.36e-04 | 19 | 58 | 2 | EFO_0009751 | |
| Disease | albuminuria | 8.51e-04 | 94 | 58 | 3 | EFO_0004285 | |
| Disease | colon adenocarcinoma (is_marker_for) | 1.11e-03 | 25 | 58 | 2 | DOID:234 (is_marker_for) | |
| Disease | QRS-T angle | 1.20e-03 | 106 | 58 | 3 | EFO_0020097 | |
| Disease | urate measurement, bone density | 1.33e-03 | 619 | 58 | 6 | EFO_0003923, EFO_0004531 | |
| Disease | chronotype measurement | 1.66e-03 | 882 | 58 | 7 | EFO_0008328 | |
| Disease | social communication impairment | 1.81e-03 | 32 | 58 | 2 | EFO_0005427 | |
| Disease | hyperuricemia | 1.93e-03 | 33 | 58 | 2 | EFO_0009104 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KEYKLALLQCYGRYL | 141 | Q96N23 | |
| RMPQLLAYYYKCHKV | 216 | P83436 | |
| KYHNDPRFISYCLKF | 61 | O43683 | |
| FYLYKHRTRPKVQYN | 3506 | Q96PZ7 | |
| IKGPLEDIYKIYCYH | 176 | Q9NXL2 | |
| QYFREKYTLQLKYPH | 311 | Q9H9G7 | |
| RKCTKYNAVYQILHY | 416 | Q96F81 | |
| DYKLVQKVCPDYNYH | 241 | O95156 | |
| YRNKYKAPTDYCLVL | 456 | Q70E73 | |
| YLPYGSLRDYLQKHK | 931 | O60674 | |
| TKHLCYCLYRPRKYL | 261 | Q86VD1 | |
| LVNHYYCKRPIYEFK | 271 | Q96MP8 | |
| YKRYRCFVLYKLPNL | 101 | Q9H2I8 | |
| YCEKVFPLAEYRTKH | 526 | Q86T24 | |
| YYPCYLKVSHRDILG | 1326 | Q9Y3R5 | |
| YLYRHNYCSKDKIPI | 656 | P08069 | |
| CLHYYYKLKNNTRIC | 656 | Q92824 | |
| YDRYAAVCKPLHYTI | 126 | Q8NHA6 | |
| LKLYRTKLIYHTYCE | 171 | A6NMU1 | |
| YLYTLEKVCQPLYNH | 236 | Q96JB1 | |
| VTVYGRKHCYRLYTK | 1466 | Q9HD67 | |
| STKYCRPYRVYKNQI | 661 | Q96BY6 | |
| YIYPKHLKYDSQKCF | 676 | Q96BY6 | |
| YIRYLYKLCDLHKEC | 1216 | Q14185 | |
| YYYISKPIHQHEDRC | 126 | P20827 | |
| YLYHQIGCCYKAKVR | 276 | O14879 | |
| PKNVYYYRCPDHRKN | 131 | Q5VU57 | |
| DNKLYRVPISHKCAY | 2031 | Q0VDD8 | |
| LKKYDLLCLYYHEPV | 46 | O14958 | |
| PKFRHNRKFYIYYSC | 281 | Q6UWX4 | |
| KSYYLCKQVRLQYEH | 266 | B5MCN3 | |
| VYASLEAYCKHKYPE | 396 | P19793 | |
| YQFKKSPYLHPCVRE | 576 | Q8NBS3 | |
| YVARNPKDCLVSYYH | 136 | Q6IMI6 | |
| YKYYRDKHLKYTPCV | 411 | Q9GZV8 | |
| CLPFIVKHAYNLYKE | 136 | A0A494BZU4 | |
| YRPYCKKNPQHLYSF | 881 | Q149N8 | |
| SYDRYVAICKPLHYT | 116 | Q9NZP0 | |
| RLSKIHLEKYPNYKY | 676 | P35712 | |
| NRLYVQYYHCTYKKR | 231 | Q5QGZ9 | |
| DPCHFYIRKYSQIKD | 426 | Q9BXT8 | |
| DYLYQPSYRKFIKLH | 1276 | Q63HN8 | |
| AIKHRRKYPDCYYNL | 576 | Q5T4D3 | |
| AYHYDPCYKKSELHK | 486 | Q9UM82 | |
| AYVLPKLYVKLHYCV | 61 | Q5JNZ5 | |
| RNPKHELTAKYLNYY | 171 | Q92791 | |
| TLYILAYLHYCPRKR | 81 | Q9BRV3 | |
| QPVRKKFSDCYIIHY | 181 | P63133 | |
| EKATLPYRHTAICYY | 101 | Q3MJ13 | |
| LLIHTRKKYYTCNYC | 296 | A6NDX5 | |
| FRKKNHVCQYYIYEL | 316 | Q9NTJ3 | |
| HKNYIKRYCPYQNIK | 616 | Q4J6C6 | |
| HYYYFLPLKKRNLDL | 156 | Q8IVQ6 | |
| KHNELKPYKCQLCYY | 2321 | Q96JM2 | |
| KPYKCQLCYYETKHT | 2326 | Q96JM2 | |
| AYVLPKLYVKLHYCV | 61 | P62854 | |
| YECKHTKINPDYNYT | 326 | Q9UI33 | |
| RLSKQHLEKYPDYKY | 611 | P35711 | |
| TQQHYYDKCPKRVYY | 71 | P06737 | |
| YYCKIRGCDKSYTHP | 551 | Q96T25 | |
| YQELPKYLRGYHKCT | 2016 | Q13402 |